

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+7.35%
-0.18%
+13.64%
+4.94%
+13.77%
RVMD
Revolution Medicines Inc.
$58.14
Strengths

Upgraded on attractively valued

Outperform the market
Chart
$46.13 (+26.04%)
$36.63 (+58.72%)
$40.38 (+43.98%)
$59.1 (-1.62%)
RVMD has Moderate Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

RVMD overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Has been gaining momentum
Activity
Activity
Future
Future

Outperform the market
![]()
RVMD Analysts opinion is positive and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
RVMD Street view is extremely bullish and have positive views on the near-term outlook
Average key support and resistance price levels.
Login to displayRVMD Earnings
The TTM reflects 12-month period, providing review of RVMD financial performance.
The company financial health is gradually deteriorating, indicating rising risks and weakening fundamentals
Financial Score
What is RVMD current stock price?
What are RVMD stock strengths?
What risks are associated with RVMD stock?
When is RVMD next earnings report?
What is RVMD market cap and volume?
What is RVMD's current Stock IQ?
Should I buy RVMD stock right now?
Is RVMD a Strong Buy right now?
What does a 'Strong Buy' rating mean for RVMD?
What does a 'Strong Sell' rating mean for RVMD?
What factors influence RVMD's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+7.35%
-0.18%
+13.64%
+4.94%
+13.77%
RVMD
Revolution Medicines Inc.
Current Price
$58.14
Stock Insights
Strengths

Upgraded on attractively valued

Outperform the market
Chart
$46.13 (+26.04%)
$36.63 (+58.72%)
$40.38 (+43.98%)
$59.1 (-1.62%)
RVMD Analysts Opinion
RVMD Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Has been gaining momentum
Activity
Activity
Future
Future

Outperform the market
![]()
RVMD Analysts opinion is positive and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
RVMD Street view is extremely bullish and have positive views on the near-term outlook
RVMD has Moderate Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

Average key support and resistance price levels.
RVMD Earnings
The TTM data reflects the most recent 12-month period, providing overview of RVMD financial performance.
RVMD Financial Health
The company financial health is gradually deteriorating, indicating rising risks and weakening fundamentals
Financial Score
RVMD Latest Analysis
Revolution Medicines to Present Updated Elironrasib Safety and Efficacy Data in Patients with KRAS G12C Non-Small Cell Lung Cancer Following Treatment with a KRAS(OFF) G12C Inhibitor.
Wed Oct 22, 2025
Mizuho Initiates Coverage of Revolution Medicines (RVMD) with Outperform Recommendation. Fintel reports that on October 21 2025 Mizuho initiated coverage of Revolution Medicines (NasdaqGS:RVMD) with a Outperform recommendation. Analyst Price Forecast Suggests 44.42% Upside
Wed Oct 22, 2025
Revolution Medicines Disc Medicine American Express And Other Big Stocks Moving Higher On Friday. United States stocks were mostly higher with the Dow Jones index gaining more than 150 points on Friday.Shares of RVMD) rose sharply during Friday'.s session after the company announced that the FDA granted the company a non-transferrable voucher for daraxonrasib the company’.s RAS(ON) multi-selective inhibitor under the Commissioner’.s National Priority Voucher pilot program.Revolutio
Fri Oct 17, 2025
Stifel Reiterates Revolution Medicines (RVMD) Buy Recommendation. Fintel reports that on October 16 2025 Stifel reiterated coverage of Revolution Medicines (NasdaqGS:RVMD) with a Buy recommendation. Analyst Price Forecast Suggests 55.49% Upside
Fri Oct 17, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
RVMD Stock trends
RVMD Stock performance
RVMD Stock analysis
RVMD investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.